DMT-focused psychedelic therapy company Small Pharma is listing on the Canadian TSK Venture Exchange as it ramps up its offerings.

There were A LOT OF DEVELOPMENTS THIS WEEK, so strap on your seat belts and let’s dive into what happened this week with: MindMed ( MMED / MNMD / MMQ ), Compass Pathways (CMPS), NUMINUS (NUMI), Fieldtrip Health (FTRP / FTRPF), Mydecine ( MYCO / MYCOF), HAVN Labs ( HAVN / HAVLF), Novamind ( NM / NVMDF), Champignon Brands aka Braxia Scientific (old ticker :SHRM / new ticker: BRAX / BRAXF), Nova Mentis (NOVA / NMLSF) and Small Pharma (DMT). Timestamps: 0:00 - Intro 0:54 - MindMed's (MMED / MNMD) Project Angie Announcement 1:47 - Compass Pathways (CMPS) Q1 Financial Results Date & Business Updates 3:16 - Analyst Coverage and Buy Ratings for CMPS 4:35 - Mydecine ( MYCO / MYCOF) 2020 Financial Results & Business Highlights 9:17 - Numinus Wellness (NUMI) Q2 Financial Results 11:25 - Field Trip Health (FTRP/ FTRPF) Opens more clinics 12:19 - Novamind ( NM / NVMDF) doubling its clinics 14:25 - Champignon Brands (SHRM /SHRMF) changing its named to Braxia Scientific (BRAX / BRAXF) 15:31 - NEW DMT company that began trading on may 6th under the name SMALL PHARMA ( DMT) 17:19 - HAVN Labs (HAVN) opens a new lab in Jamaica 17:50 - Nova Mentis launches a new clinical study using psilocybin to treat autism Link to MindMed’s Project Angie Press release: https://mindmed.co/news/press-release/mindmed-announces-project-angie-targeting-the-treatment-of-pain-with-psychedelics/ Link to Compass Pathways Q1 financial Results date: https://ir.compasspathways.com/news-releases/news-release-details/compass-pathways-plc-announce-first-quarter-2021-financial Link to Compass Pathways (CMPS) analyst ratings: https://www.marketbeat.com/stocks/NASDAQ/CMPS/price-target/ Link to Mydecine ( MYCO/ MYCOF) Full Year 2020 Financial results Plus business updates https://www.globenewswire.com/news-release/2021/05/03/2221266/0/en/Mydecine-Reports-Full-Year-2020-Financial-Results-and-Provides-Business-Update.html Link to Numinus (NUMI) Q2 2021 Financial Results: https://www.newswire.ca/news-releases/numinus-wellness-q2-2021-results-highlighted-by-17-25-million-financing-mindspace-wellbeing-acquisition-and-clinical-trial-collaboration-with-maps-pbc-846735411.html Link to Field Trip’s (FTPR / FTPRF) 7th Psychedelic-assisted therapy Clinic: https://psilocybinalpha.com/news/field-trip-health-ltd-announces-opening-of-psychedelic-enhanced-therapy-center-in-houston-locations-of-next-5-field-trip-health-centers Link to Novamind’s (NM / NVMDF) Ketamine Clinic article: https://novamind.ca/2021-05-04-novamind-doubles-in-size-adds-four-new-psychedelic-mental-health-clinics/ Link to Champignon Brands ( SHRM/ SHRMF) announcing their name change to Braxia Scientific (BRAX / BRAXF): https://thedeepdive.ca/champignon-brands-to-change-name-to-braxia-scientific/ Link to Small Pharma ( DMT): https://psilocybinalpha.com/news/small-pharma-completes-reverse-take-over-transaction Link to Havn’s (HAVN / HAVLF) Jamaica lab: https://www.psychedelicfinance.com/articles/havn-labs-jamaica-facility-now-fully-operational Link to Nova Mentis launching a clinical study to learn more about Autism: https://psilocybinalpha.com/news/nova-mentis-launches-autism-clinical-study Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! 🙌 Instagram: @psychedelicinvestor Email: thepsychedelicinvestor@gmail.com Facebook: @thepsychedelicinvestor editing by: @themyaholy Music: www.bensound.com https://benzinga.grsm.io/jameshallifax1834 https://benzinga.grsm.io/thepsychedelicinvestor DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change. #MindMed #Numi #CMPS

Project Angie: Can MindMed Disrupt the Pain Relief Industry? [MMED / MNMD Expanding Horizons] Breaking NEWS: MindMed ( MNMD / MMED / MMQ ) launching a new flagship program called Angie to advance the development of psychedelics, including LSD and potentially penetrate the pain killer industry by treating pain conditions. MindMed is currently exploring two primary clinical indications for the treatment of pain: MindMed will initiate a study of LSD in a severe pain indication. MMED is currently preparing a pre-IND briefing package for this Phase 2a Proof of Concept study. They plan to submit to the FDA in the second half of 2021. ( As a note, that means they could present this doc anywhere between July 1st and December 31st. So it is conceivable that this trial could start at the tail end of 2021, if this doc gets presented at the beginning of that period.) The second indication that MindMed is evaluating is “the common, often debilitating, chronic pain syndrome”. Link to the 1964 study testing the LSDs ability to treat pain in cancer patients, and it had dual surprising results : file:///C:/Users/maria/Downloads/Study_of_Lysergic_Acid_Diethylamide_as_an.13.pdf Link to the 2020 a study was published that had among its authors 2 prominent MindMed collaborators: Mattias Liechti and Kim Kuypers: https://journals.sagepub.com/doi/full...​ Link to the 2017study: https://www.ncbi.nlm.nih.gov/pmc/arti...​ Link to MindMed ( MMED / MNMD/ MMQ ) : https://mindmed.co/​ Link to MindMed ‘ s Press Release on Project Angie : https://mindmed.co/news/press-release...​ Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! 🙌 Instagram: @psychedelicinvestor Email: thepsychedelicinvestor@gmail.com Facebook: @thepsychedelicinvestor Music: www.bensound.com https://benzinga.grsm.io/jameshallifa...​ https://benzinga.grsm.io/thepsychedel...​ DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change. #MindMed​ #MindMedStock​ #MNMD